title: [Change of pulsatile release and luteinizing hormone response to naloxone related to testicle damage].
abstract: OBJECTIVE
  To compare the pulsatile release of LH, the tone of endogenous opioids and the mass of LH secreted after a naloxone infusion in healthy subjects and patients with normogonadotropic oligospermia (NO) in a model of progressive testicular damage.
  
  
  METHODS
  Pulsatile secretion of LH was analyzed in a period of 8 hours in a group of healthy subjects (group 3, n=5), in patients with NO and FSH/LH ratio <1.6 (group 1, n=5) and in patients with NO and FSH/LH ratio >1.6 (group 2, n=5). The area under the curve of LH response after naloxone infusion was also calculated.
  
  
  RESULTS
  Free serum testosterone concentration was lower (p < 0.01) and estradiol concentration higher in patients with NO than control subjects (1 vs. 3: p = 0.01; 2 vs. 3: p = 0.001). Frequency of pulses in group 1 was 3.33 +/- 0.57/8 h, in group 2: 4 +/- 1/8 h; and in group 3: 2.66 - 0.57/8 h (2 vs. 3 p < 0.01; 2 vs. 1 p = 0.05). The area under the curve after naloxone infusion was 19,300.44 +/- 11,403.31 in group 1, 5696.09 +/- 1753.44 in group 2; and 3080.97 +/- 1159.78 in group 3 (1 vs. 3 Anova p = 0.01).
  
  
  CONCLUSIONS
  The data indicate that patients with NO have a subclinical pantesticular failure and that the opioid tone is increased at the initial phase of testicular dysfunction, but it decreases at more advanced stages of testicular damage.
authors.affiliation: Clínica de Andrología, Instituto Nacional de Parinatología, DF México. villanuevacmx@yahoo.com.mx
authors.forename: Carlos A
authors.initials: CA
authors.lastname: Villanueva Díaz
authors.forename: Rubén
authors.initials: R
authors.lastname: Pineda Viedas
authors.forename: Mirna Guadalupe
authors.initials: MG
authors.lastname: Echavarría Sánchez
authors.forename: Armando
authors.initials: A
authors.lastname: Juárez Bengoa
mesh_terms: D004958:Estradiol / Q000097:blood; D006801:Humans; D007986:Luteinizing Hormone / Q000187:drug effects* / Q000378:metabolism*; D008297:Male; D009270:Naloxone / Q000494:pharmacology*; D009845:Oligospermia / Q000097:blood / Q000503:physiopathology*; D018847:Opioid Peptides / Q000097:blood; D013733:Testicular Diseases / Q000097:blood / Q000503:physiopathology*; D013739:Testosterone / Q000097:blood
chemical_list: D018847:Opioid Peptides; D009270:Naloxone; D013739:Testosterone; D004958:Estradiol; D007986:Luteinizing Hormone